newly
diagnosed
treatment
information
research &
trials
webcasts find
support
seminars
& meetings
events doctors nurses advocacy about
IMF
helping
the IMF
 
      International Myeloma Working Group     
 

:
Help fund research and important educational programs.
more..

WHAT IS MYELOMA? : more..


PATIENT SERVICES : Reimbursement, legal, and other services.
more..

MYELOMA MANAGER™ : Capture your lab results and see how they change over time. more..

NEXPROFILER™ :
Treatment information tailored to your diagnosis.
more..

FREE MYELOMA INFO PACK : Order one today. more..

Read the MYELOMA MINUTE :
Our free e-mail newsletter.
more..

Read MYELOMA TODAY :
And get a free subscription.
more..

IMF Privacy Policy : The IMF is committed to protecting the security of your personal and health information. more..

Share via del.icio.us Share via Digg

The IMF’s International Myeloma Working Group consists of 109 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. With a goal to improve myeloma treatment options and diagnostic systems, their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, addressing the needs of both myeloma patients and the physicians who treat them.

Publications:
10.02.09     International Myeloma Working Group (IMWG) Molecular Classification of Multiple Myeloma: Spotlight Review
Published in Leukemia (2009), 1–12
08.05.09     International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
Published in Leukemia (2009), 1–9
05.28.09     International Myeloma Working Group Consensus Statement and Guidelines Regarding the Current Role of Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma
Published in Leukemia (2009), 1–12
11.23.08     International Myeloma Working Group guidelines for serum free light chain analysis in multiple myeloma and related disorders
Spotlight Review
Published in Leukemia (2008), 1–10
11.19.08     The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
Published in Leukemia advance online publication, 29 May 2008; 1–6
05.15.08     Myeloma in patients under age 50 presents with more favorable features and shows better survival: an analysis of 10,549 patients from the International Myeloma Working Group
Published in Blood, 15 April 2008, Vol. 111, No. 8, pp. 4039-4047
05.01.08     Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma
Published in Haematologica 2008 May;93(5):791-792
12.20.07     Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Published in Leukemia (2008) 22, 414–423
04.25.07     International uniform response criteria for multiple myeloma
Published in Leukemia (2006), 1–7
04.01.07     Use of Bisphosphonates in Multiple Myeloma: IMWG Response to Mayo Clinic Consensus Statement
Published in the Mayo Clinic Proceedings 2007;82:516-522
04.04.05     International Staging System for Multiple Myeloma
Published in the Journal of Clinical Oncology. Published Ahead of Print on April 4, 2005 as 10.1200/JCO.2005.04.242
12.19.03     Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
Published in the British Journal of Haematology, 2003, 121, 749–757
01.30.03     Myeloma Management Guideline: a consensus report from the Scientific Advisors of the Internatioanl Myeloma Foundation
Published in The Hematology Journal (2003) 4, 379-398.

We thank our web site sponsors

Amgen

Binding Site

Celgene Corporation

Proteolix

We welcome our international partners:
Canada Czech Republic Europe Israel Japan Latin America
Copyright 2009. International Myeloma Foundation. All Rights Reserved.

International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
USA
phone: 800-452-2873 (US and Canada)
818-487-7455 (elsewhere)
fax: 818-487-7454
email: TheIMF@myeloma.org